Our Work

Experience built in complex capital environments.

Glengarra has supported major capital investments across multiple markets and geographies, from investment definition and optimisation through programme integration, project controls, delivery and recovery.

>€2Bn Capital projects supported
€100m–600m+ Individual programme scale
Europe · Asia · Global Project and portfolio experience

The Problem

Major capital projects routinely run over cost and schedule.

79% Average cost overrun
52% Average schedule overrun

McKinsey analysis of 532 projects globally valued at $100m+. Source →

Better project practices materially change the position.

10–15% CAPEX improvement potential

Alongside schedule improvement and reduced contingency consumption.

BCG Capital Project Excellence. Source →

Why It Matters

Capital project performance is business performance.

In high-value manufacturing environments, project performance extends beyond construction cost: it shapes when a facility can produce, and how confidently leadership can commit capital.

Capital at risk.Time at risk.Product at risk.Decisions at risk.

The Glengarra ~1% Philosophy

~1%

Protect the other 99%.

We believe owners should consider reserving around 1% of capital investment for the independent challenge, optimisation, assurance and specialist support required to protect project value from definition through delivery.

CHF100m Total investment
~CHF1m Dedicated to protecting project performance

A small proportion of the investment. Focused on protecting the whole.

This is not a fixed fee, and not the right level of spend for every project. It is an owner-side capital protection principle, not a guarantee of return.

The Value Equation

Where the value actually sits.

Value Created

10–15%+ Potential direct CAPEX opportunity

Scope · Design · Procurement

Value Protected

10%+ Potential indirect / delivery opportunity

Schedule · Contingency · Commercial position

Value Identified

Earlier Visibility

Risk exposure · Forecast uncertainty · Decision options

These are indicative value-at-stake / improvement ranges, not guarantees. Value at stake should materially exceed the cost of intervention.

What We Deliver

Six ways the position changes.

Reduce Cost

Challenge scope, design, specification, technology and procurement: direct and indirect cost alike.

Protect Time

Identify critical-path exposure and protect schedule and business milestones.

Increase Confidence

Build one credible position across forecast, progress, risk and contingency.

Remove Risk Earlier

Surface exposure while there is still time and optionality to respond to it.

Strengthen Execution

Clarify responsibilities, interfaces, governance and controls on site.

Improve Decisions

Give leadership independent, connected information for better capital and delivery decisions.

Strategy. Results. It’s our nature.

Complex terrain. Clearer decisions.

Independent judgement matters most when the route is complex, the exposure is high and decisions still have room to change the outcome.

Prove It

The impact of our work.

Material outcomes across complex capital investments.

Switzerland · Biotechnology

One major programme, evidenced across capital, delivery cost and schedule.

>20%

Capital requirement optimised

>10%

Indirect delivery cost avoided

Critical Milestone

Schedule value preserved

Belgium · Life Sciences

±20% → ±10%

Investment confidence improved

A stronger estimate baseline supported commitment before execution began.

Ireland · Technical Operations

Under Budget

Brownfield investment delivered

A complex, live-site transformation delivered within the committed investment.

Value Is More Than Savings

Value isn’t always a saving.

  • Exposure identified before it materialises is value.

  • A critical business milestone protected can outweigh construction-cost savings.

  • A forecast leadership can trust changes the decisions available.

Experience Grounded in Delivery

Switzerland · Lonza · Greenfield Biologics Facility

CHF600m+ Total programme value
700+ Technical equipment systems

As PMO & Project Services partner, Glengarra integrated controls, contracts and turnover coordination across a CHF600m+ greenfield biologics programme spanning 700+ technical equipment systems.

Visp, Switzerland: the scale of a single capital-project campus.

Experience Behind the Advice

Experience behind the advice.

Our experience spans investment definition, assurance, governance, recovery and delivery across complex capital environments internationally.

Germany · Pharmaceutical Manufacturing

Restored control of cost, schedule and execution.

Scotland · Advanced Manufacturing

Created one integrated position for confident owner decisions.

China · API & Excipient Production

Strengthened investment definition before major capital commitment.

Ireland · Technical Operations

Optimised the investment and delivered below budget.

Global · Project Delivery

Turned project risk into consistent management intelligence.

Belgium · Life Sciences

Strengthened estimate confidence ahead of investment commitment.

How We Get There

These outcomes are delivered through our Strategic Services.

Explore Strategic Services

Purpose

Capital projects should perform better. That is why we exist.

Our mission is to bring strategy together with delivery expertise: protecting scope, time and cost on complex capital investments, and giving owners the independent view they need to act with confidence.

Right capability. Right time. Right outcome.

Trusted Across Complex Capital Delivery

Merck Lonza Sanofi Kenvue dsm-firmenich Siegfried UCB Clariant DPR Construction Amelicor Group

Strategy. Results. It’s our nature.

What could we change on your project?

Bring us a live investment case, a major project challenge or an early-stage strategy, and we’ll give you a clear, independent view of where the value and exposure actually sit.